A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Clinical trial NCT04564027 · COMPLETED

Trial details

NCT number: NCT04564027
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumours

Start date: 2020-12-01
Primary completion: 2025-02-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.